Article
Seronegative spondyloarthropathies: to lump or split?
Annals of the rheumatic diseases - 1 Mar 2005
Nash P, Mease P J, Braun J, van der Heijde D
Abstract excerpt
The advent of novel biological therapies for the treatment of rheumatic disease has renewed interest in the seronegative spondyloarthropathies (SpAs). International efforts are redefining disease classification and measures of disease activity, outcome, metrology, and imaging. However, opinion is divided between those who propose that the SpA group represents the same disease with variable expression (the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
